According to a new report from Tufts Center for the Study of Drug Development (Tufts CSDD), although many pharmaceutical companies are increasing the pace of new products by improving the efficiency of clinical trial operations, their medium- and long-term success will increasingly depend on their ability to support more efficient research and development (R&D) models.
President Obama: Support Medical Research for Jobs
September 5, 2011 | by Walter Jessen
Health research plays an essential role in the nation’s economic growth while improving health for patients in the United States and around the world. A recent public opinion survey commissioned by Research!America indicates that up to 78% of Americans think it is important that the U.S. work to improve health globally through research and development and 76% think global health R&D is important to the U.S. economy [1]. Moreover, 61% of respondents say that accelerating our nation’s investment in research to improve health is a priority.